There was no difference in OS between treatments in the low hENT1 subgroup or overall , with hazard ratios ( HRs ) of 0.994 ( 95 % CI , 0.746 to 1.326 ) and 1.072 ( 95 % CI , 0.856 to 1.344 ) , respectively .